New research provides insights on why drug treatments for addiction and depression fail to work for some people.
Investigators from Washington University School of Medicine in St. Louis believe the inconsistent effect is linked to the brain’s reward and dislike (aversion) pathways.
The research appears in the journal Neuron.
“We studied the neurons that cause activation of kappa opioid receptors, which are involved in every kind of addiction — alcohol, nicotine, cocaine, heroin, methamphetamine,” said principal investigator Michael R. Bruchas, Ph.D., associate professor of anesthesiology and neurobiology.
“We produced opposite reward and aversion behaviors by activating neuronal populations located very near one another. This might help explain why drug treatments for addiction don’t always work — they could be working in these two regions at the same time and canceling out any effects.”
Addiction can result when a drug temporarily produces a reward response in the brain that, once it wears off, prompts an aversion response that creates an urge for more drugs.
The researchers studied mice genetically engineered so that some of their brain cells could be activated with light. Using tiny, implantable LED devices to shine a light on the neurons, they stimulated cells in a region of the brain called the nucleus accumbens, producing a reward response. Cells in that part of the brain are dotted with kappa opioid receptors involved in addiction and depression.
“We were surprised to see that activation of the same types of receptors on the same types of cells in the same region of the brain could cause different responses,” said first author Ream Al-Hasani, Ph.D., an instructor in anesthesiology.
“By understanding how these receptors work, we may be able to more specifically target drug therapies to treat conditions linked to reward and aversion responses, such as addiction or depression.”
This article first appeared on ‘Psych Central’ on 8 September 2015.